Some studies showed that NKp44 and other NCRs usually have an important role in the lysis mediated by NK cells in various tumors, including carcinomas, melanomas, neuroblastomas, myeloid and lymphoblastic leukemia, multiple myeloma, and B cells transformed by the Epstein-Barr virus [34]. This evidence concerns the gene NCR2 and melanoma.